• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Coronavirus Disease 2019: The Role of the Fibrinolytic System from Transmission to Organ Injury and Sequelae.2019冠状病毒病：纤维蛋白溶解系统在从传播到器官损伤及后遗症过程中的作用
Semin Thromb Hemost. 2020 Oct;46(7):841-844. doi: 10.1055/s-0040-1709996. Epub 2020 May 9.
2
Circulating Plasminogen Concentration at Admission in Patients with Coronavirus Disease 2019 (COVID-19).2019冠状病毒病（COVID-19）患者入院时的循环纤溶酶原浓度
Semin Thromb Hemost. 2020 Oct;46(7):859-862. doi: 10.1055/s-0040-1715454. Epub 2020 Sep 3.
3
Thrombosis and Hemostasis Issues in Cancer Patients with COVID-19.新冠肺炎癌症患者的血栓形成与止血问题
Semin Thromb Hemost. 2020 Oct;46(7):785-788. doi: 10.1055/s-0040-1714275. Epub 2020 Aug 12.
4
Incidence of heparin-induced thrombocytopenia in patients with 2019 coronavirus disease.2019冠状病毒病患者肝素诱导的血小板减少症的发病率
Med Clin (Barc). 2020 Nov 13;155(9):409-410. doi: 10.1016/j.medcli.2020.05.041. Epub 2020 Jul 28.
5
Plasmacytoid lymphocytes in SARS-CoV-2 infection (Covid-19).新型冠状病毒2型感染（新冠肺炎）中的浆细胞样淋巴细胞
Am J Hematol. 2020 Jul;95(7):861-862. doi: 10.1002/ajh.25834. Epub 2020 Apr 28.
6
Coronavirus Disease 2019 Coagulopathy: Disseminated Intravascular Coagulation and Thrombotic Microangiopathy-Either, Neither, or Both.2019冠状病毒病凝血障碍：弥散性血管内凝血和血栓性微血管病——是其一、均不是或两者皆是。
Semin Thromb Hemost. 2020 Oct;46(7):781-784. doi: 10.1055/s-0040-1712156. Epub 2020 Jun 8.
7
COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation.COVID-19：凝血功能障碍、血栓形成风险和抗凝治疗的理由。
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620938149. doi: 10.1177/1076029620938149.
8
Free-floating right heart thrombus with pulmonary embolism in SARS-CoV-2 patient.新型冠状病毒肺炎患者出现游离性右心血栓伴肺栓塞
Med Clin (Barc). 2020 Nov 13;155(9):415-416. doi: 10.1016/j.medcli.2020.06.014. Epub 2020 Jul 4.
9
Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad.新冠肺炎（COVID-19）中的血栓形成——从维柯氏三联征的角度来看。
Clin Rheumatol. 2020 Sep;39(9):2529-2543. doi: 10.1007/s10067-020-05275-1. Epub 2020 Jul 11.
10
Thrombolysis restores perfusion in COVID-19 hypoxia.溶栓治疗可恢复新冠肺炎低氧血症患者的灌注。
Br J Haematol. 2020 Sep;190(5):e270-e274. doi: 10.1111/bjh.17050. Epub 2020 Aug 17.

引用本文的文献

1
Potential Nephroprotective Effect of uPA against Ischemia/Reperfusion-Induced Acute Kidney Injury in αMUPA Mice and HEK-293 Cells.尿激酶型纤溶酶原激活剂（uPA）对αMUPA小鼠和人胚肾细胞系293（HEK-293）细胞缺血/再灌注诱导的急性肾损伤的潜在肾保护作用。
Biomedicines. 2024 Oct 12;12(10):2323. doi: 10.3390/biomedicines12102323.
2
Transcriptomic analysis of profibrinolytic and fibrinolytic inhibitor genes in COVID-19 patients.新冠病毒感染患者中纤溶酶原激活物和纤溶酶原激活物抑制剂基因的转录组分析
Narra J. 2024 Aug;4(2):e843. doi: 10.52225/narra.v4i2.843. Epub 2024 Jul 5.
3
Aprotinin (II): Inhalational Administration for the Treatment of COVID-19 and Other Viral Conditions.抑肽酶（II）：用于治疗 COVID-19 和其他病毒病的吸入式给药。
Int J Mol Sci. 2024 Jun 29;25(13):7209. doi: 10.3390/ijms25137209.
4
Fibrinolytic system and COVID-19: From an innovative view of epithelial ion transport.纤维蛋白溶解系统与 COVID-19：从上皮细胞离子转运的创新视角看。
Biomed Pharmacother. 2023 Jul;163:114863. doi: 10.1016/j.biopha.2023.114863. Epub 2023 May 9.
5
Status of major hemostatic components in the setting of COVID-19: the effect on endothelium, platelets, coagulation factors, fibrinolytic system, and complement.新型冠状病毒肺炎背景下主要止血成分的状态：对血管内皮、血小板、凝血因子、纤维蛋白溶解系统和补体的影响。
Ann Hematol. 2023 Jun;102(6):1307-1322. doi: 10.1007/s00277-023-05234-1. Epub 2023 Apr 19.
6
The potential impact of Covid-19 on the capacity of routine laboratory tests to detect heparin-induced thrombocytopenia.新冠病毒病（Covid-19）对常规实验室检测肝素诱导的血小板减少症能力的潜在影响。
Thromb J. 2022 Sep 26;20(1):55. doi: 10.1186/s12959-022-00411-0.
7
Dysregulated miRNAs network in the critical COVID-19: An important clue for uncontrolled immunothrombosis/thromboinflammation.调控失常的 microRNA 网络与危重症 COVID-19：失控性免疫血栓形成/血栓炎症的重要线索。
Int Immunopharmacol. 2022 Sep;110:109040. doi: 10.1016/j.intimp.2022.109040. Epub 2022 Jul 11.
8
Protection by metformin against severe Covid-19: An in-depth mechanistic analysis.二甲双胍对严重 COVID-19 的保护作用：深入的机制分析。
Diabetes Metab. 2022 Jul;48(4):101359. doi: 10.1016/j.diabet.2022.101359. Epub 2022 May 31.
9
Does COVID-19 infection increase the risk of pressure injury in critically ill patients?: A narrative review.新型冠状病毒肺炎感染是否会增加危重症患者发生压力性损伤的风险？：一项叙述性综述。
Medicine (Baltimore). 2022 Mar 18;101(11). doi: 10.1097/MD.0000000000029058.
10
Subacute dual stent thromboses in a COVID-19-positive patient.COVID-19 阳性患者的亚急性双重支架血栓形成。
Cardiovasc J Afr. 2022;33(6):329-332. doi: 10.5830/CVJA-2022-003. Epub 2022 Mar 24.

本文引用的文献

1
Is there a role for tissue plasminogen activator as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome?组织型纤溶酶原激活剂作为难治性新型冠状病毒肺炎相关急性呼吸窘迫综合征的一种新型治疗方法，是否具有作用？
J Trauma Acute Care Surg. 2020 Jun;88(6):713-714. doi: 10.1097/TA.0000000000002694.
2
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis.中国 COVID-19 患者 1590 例的合并症及其影响：一项全国性分析。
Eur Respir J. 2020 May 14;55(5). doi: 10.1183/13993003.00547-2020. Print 2020 May.
3
[A pathological report of three COVID-19 cases by minimal invasive autopsies].[三例新冠病毒病病例微创尸检病理报告]
Zhonghua Bing Li Xue Za Zhi. 2020 May 8;49(5):411-417. doi: 10.3760/cma.j.cn112151-20200312-00193.
4
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.2019 冠状病毒病（COVID-19）疫情的起源、传播和临床治疗——现状更新。
Mil Med Res. 2020 Mar 13;7(1):11. doi: 10.1186/s40779-020-00240-0.
5
[Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia].[RAS 抑制剂可能是治疗 COVID-19 肺炎的良好选择]
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Mar 12;43(3):219-222. doi: 10.3760/cma.j.issn.1001-0939.2020.03.016.
6
Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer.两例肺癌患者 2019 年新型冠状病毒（COVID-19）肺炎早期阶段的肺部病理学表现。
J Thorac Oncol. 2020 May;15(5):700-704. doi: 10.1016/j.jtho.2020.02.010. Epub 2020 Feb 28.
7
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
8
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.中国武汉严重 COVID-19 患者的临床病程和结局：一项单中心、回顾性、观察性研究。
Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24.
9
A pneumonia outbreak associated with a new coronavirus of probable bat origin.一种新型冠状病毒引发的肺炎疫情，该病毒可能来源于蝙蝠。
Nature. 2020 Mar;579(7798):270-273. doi: 10.1038/s41586-020-2012-7. Epub 2020 Feb 3.
10
Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus.新型冠状病毒受体识别：基于 SARS 冠状病毒长达十年结构研究的分析。
J Virol. 2020 Mar 17;94(7). doi: 10.1128/JVI.00127-20.

Coronavirus Disease 2019: The Role of the Fibrinolytic System from Transmission to Organ Injury and Sequelae.

作者信息

Kwaan Hau C

机构信息

Division of Hematology-Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

出版信息

Semin Thromb Hemost. 2020 Oct;46(7):841-844. doi: 10.1055/s-0040-1709996. Epub 2020 May 9.

DOI:10.1055/s-0040-1709996
PMID:32386428
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7672661/
Abstract
摘要